An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy
Clinical trial NCT01703988 · COMPLETED
Trial details
- NCT number
- NCT01703988
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-31
- Primary completion
- 2015-01-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.